Medistep Healthcare Limited IPO

Medistep Healthcare Limited IPO is of ₹16.10 crores, consisting of 37.44 lakh fresh equity shares. The IPO is to be subscribed publicly between 8th August, 2025 to 12th August, 2025. Retail investors can apply for a minimum lot size of 6,000 shares, which will be of ₹2,58,000 and HNIs can apply for 9,000 shares of ₹3,87,000. Allotment will be completed on 13th August 2025, with the shares likely to be listed on the NSE SME platform on 18th August 2025.

Company Background

Established in 2023 in Ahmedabad, Gujarat, Medistep became a dynamic healthcare and pharmaceutical corporation that offers a vast variety of products from sanitary pads to nutraceutical products and more. The company is strongly focused on providing innovative, high-quality health care solutions. Medistep works in a business that’s a combination of both manufacturing and distribution of products and services offered by the company. With a strong sense of quality control, customer service and expansion plans, the company has rapidly placed itself as a notable brand in the healthcare industry.

Operations & Product Range

Facility and Services

The company currently operates its manufacturing facility, which is located in the Kheda district of Gujarat and covers approximately 371.61 square meters. The company has a strong focus on manufacturing and trading a variety of healthcare products, which include the production of sanitary pads under the brand name Drystep and energy powders under the brand name Vitastep. Along with that, Medistep also manufactures nutraceutical, pharmaceutical, Intimate care and surgical products.

Brand and Market Presence

Medistep, along with its key in-house brands by the name of Drystep and Vitastep, has established a good presence in both domestic and international healthcare markets. The company has a strong regional foothold in Gujarat and aims for a wide market presence. It currently distributes various products to well-known clients like Astha Multispeciality Hospital, Ocean Multispeciality Hospital, Rudraksha Institute of Medical Sciences, Sadguru Hospital, Unity Hospital and Sunrise Hospital.

Revenue Channels

A revenue growth from ₹39.07 crore in FY24 to ₹49.65 crore in FY25 was witnessed by Medistep. The company gains its revenue primarily from two main sources -

1. 1. The company gains a major part of its revenue through its manufacturing of sanitary pads under Drystep and energy powders under Vitastep, which cater to the healthcare and wellness sectors.
2. 2. Medistep also earns revenue through the distribution of a diverse range of nutraceutical, pharmaceutical, surgical and personal care products, which helps in the expansion of the company’s market presence.

Management & Shareholding

Promoters and Shareholders

Medistep Healthcare Limited IPO is promoted by Mr. Girdhari Lal Pratap, Mr. Dabhi Vipul Gobarbhai, Ms. Prajapati Hetalben Girdharilal and Mr. Jagdish Prajapati. The promoters have approximately 93.62% stake in the company and are expected to reduce to 68.96% after the company’s IPO listing on 8th August.

Board Members

The board group of Medistep Healthcare Limited includes various managerial experts who have a good amount of experience in the healthcare industry, like, Girdhari Lal Prajapat, who is the Managing Director of Medistep, as well as Vipul Gobarbhai Dabhi, Anandbhai Jitendrabhai Khoda, Kapilbhai Raysinhbhai Dodiya and Hetalben Shankarlal Prajapati, who are the Directors of the company.